One of the most important principles of sound investment management is staying on top of what’s happening in the world and how those events affect finances. Conditions change quickly, and keeping up-to-date on developments and trends can be challenging. The team of experts producing IWB have been advising Canadian investors for over 25 years.
Edited and Published by Gordon Pape. Associate Editor: Richard Croft
With Gavin Graham, Ryan Irvine, Glenn Rogers, Shawn Allen, Adam Mayers, Paul Bamford & Michael Corcoran.
Recent Issues
iwb22327 (July 24, 2023)
ARK ETF still struggling… The boom/bust paradox… Richard Croft updates Goldman Sachs, Paramount Global… Gordon Pape updates Canadian Utilities, UnitedHealthcare, J.B. Hunt Transport… Financial Factoids: Warren Buffett… Members’ Corner: Babylon Holdings… Your Questions: Sell TC Energy?
iwb22326 (July 17, 2023)
Predictions and probabilities… Adjust your fixed income allocations… Shawn Allen updates Ceapro Inc., West Fraser Timber… Gordon Pape updates EQB Inc…. Gavin Graham updates Manulife Financial, Jeffries Financial Group… Financial Factoids: Elon Musk… Members’ Corner: Trading volume… Correction: ARC Resources
iwb22325 (July 10, 2023)
No recession – yet… ARC looks attractive… Buy humiliation, sell hubris… Gavin Graham updates iShares MSCI UK ETF, Fairfax Financial, iA Financial Group… Gordon Pape updates iShares Core US Aggregate Bond ETF, iShares Edge MSCI Minimum Volatility USA Index ETF (CAD-Hedged), BMO Low Volatility US Equity Hedged to CAD ETF… Your Questions: ETF volume… Housekeeping
iwb22324 (June 26, 2023)
Surprise! Stocks that bucked the trend… Big 3 grocers profit amidst slowdown… Adam Mayers updates Nvidia, CAE, Canadian Solar… Gordon Pape’s stock updates: Telus, Richelieu Hardware… Gordon Pape’s ETF updates: CI First Asset Morningstar Canada Value Index ETF, Harvest Tech Achievers Growth and Income ETF, iShares Core S&P US Total Market ETF… Your View: The bulls have it!
Recent Updates
Pfizer Inc. (NYSE: PFE)
Pfizer is a leading international pharmaceutical company that can trace its history back more than 170 years. Its business units include Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines, and Internal Medicine. Pfizer was the first company (along with partner BioNTech) to have a Covid vaccine approved for general use. It has proven to be highly effective with minimal side effects. The company has also developed a drug to treat the virus.
Hold
Winpak Ltd. (TSX: WPK, OTC: WIPKF)
Winpak produces goods that are mainly used in the food and beverage and healthcare industries. Its modified atmosphere packaging is used to extend the shelf life of perishable products such as meat, poultry, and cheese as well as healthcare products. The majority of its sales are in North America.
Buy
Cameco Corp. (TSX: CCO, NYSE: CCJ)
Cameco is one of the world’s largest uranium producers, with mines at McArthur River and Cigar Lake in Saskatchewan and refineries in Ontario. As governments and investors have become more favourably inclined towards non-carbon emitting sources of baseload power such as nuclear in recent years, Cameco’s fortunes and its share price have revived.
Sell half
CGI Group (TSX: GIB.A, NYSE: GIB)
CGI is the fifth largest independent information technology and business process services firm in the world. The company, founded in 1976, delivers an end-to-end portfolio of capabilities, from IT and business consulting to systems integration, outsourcing services, and intellectual property solutions. It employs about 93,000 professionals in offices and delivery centres across the Americas, Europe, and the Asia Pacific region.
Hold
Bank of Nova Scotia (TSX, NYSE: BNS)
Scotiabank is the most internationally diversified of the major Canadian banks, with over 30% of its assets coming from its overseas operations, primarily what the bank describes as the three Pacific Alliance countries of Mexico, Peru, and Chile. It sold its subscale operations in Colombia, Panama, and Costa Rica to bank Davivienda in the first quarter in exchange for a 20% stake in Davivienda, taking a $1.4 billion impairment charge on the sale. Scotiabank has strengths in mortgage and corporate lending and wealth management and is usually the lowest cost operator amongst the major banks.